Scienture Holdings SCNX
NASDAQ SCNX
$0.37 +0.01 (+1.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scienture Holdings (SCNX) Non-Current Assets (2013 - 2026)

Scienture Holdings' (SCNX) quarterly Non-Current Assets came in at $78.5 million in Q2 2026, down 5.75% year-over-year from $83.3 million in Q2 2025, and up 3.48% quarter-over-quarter from $75.9 million in Q1 2026.

Analysis

Scienture Holdings (SCNX) Non-Current Assets (2013 - 2026) Analysis & Trends

Scienture Holdings has disclosed Non-Current Assets across 14 years of filings, most recently posting $78.5 million for Q2 2026.

  • In Q2 2026, Non-Current Assets fell 5.75% year-over-year to $78.5 million; the TTM figure through Jun 2026 stood at $314.0 million (up 20.34% YoY), while the FY2025 annual figure was $76.3 million, down 22.61% from the prior year.
  • Non-Current Assets came in at $78.5 million for Q2 2026 at Scienture Holdings, up from $75.9 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $98.5 million in Q4 2024 to a low of $1.6 million in Q4 2022.
  • Average Non-Current Assets over 5 years is $41.3 million, with a median of $16.1 million recorded in 2023.
  • Year-over-year, Non-Current Assets slipped 24.41% in 2024 and soared 2981.32% in 2025.
  • Over 5 years, Non-Current Assets stood at $1.6 million in 2022, then surged by 504.85% to $9.8 million in 2023, then jumped by 907.67% to $98.5 million in 2024, then dropped by 22.61% to $76.3 million in 2025, then advanced by 2.98% to $78.5 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $78.5 million in Q2 2026, $75.9 million in Q1 2026, and $76.3 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 26.10 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 24.99 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 2.92 Bn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 1.83 Bn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 18.27 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 668.68 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 1.04 Bn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 1.11 Bn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 3.25 Mn
10 Scienture Holdings 15.19 Mn 15.19 Mn 335,779.00 78.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 78.53 Mn
Mar 31, 2026 75.89 Mn
Dec 31, 2025 76.26 Mn
Jun 30, 2025 83.32 Mn
Mar 31, 2025 76.35 Mn
Dec 31, 2024 98.55 Mn
Jun 30, 2024 2.70 Mn
Mar 31, 2024 90.83 Mn
Dec 31, 2023 9.78 Mn
Sep 30, 2023 16.11 Mn
Jun 30, 2023 3.58 Mn
Dec 31, 2022 1.62 Mn
Sep 30, 2022 2.11 Mn
Jun 30, 2022 2.33 Mn
Mar 31, 2022 2.24 Mn
Dec 31, 2021 1.39 Mn
Sep 30, 2021 324,827.00
Jun 30, 2021 359,863.00
Mar 31, 2021 537,976.00
Dec 31, 2020 571,404.00